Drug intelligence / Profile preview

YFZ-3BY

Development stage: Preclinical
Lead developer: Yifan Pharmaceutical

Overview

**YFZ-3BY** is an unnamed traditional Chinese medicine candidate being developed by Yifan Pharmaceutical for a gynecological traditional Chinese medicine indication described as yin deficiency with internal heat and blood disorder. The company pipeline lists the program as undergoing pharmaceutical research; its active constituents, molecular targets, pharmacologic mechanism, dosage form, and route of administration have not been publicly disclosed. ([en.yifanyy.com](https://en.yifanyy.com/innovation/pipeline.html))

Beyond the preview

Go deeper on YFZ-3BY.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YFZ-3BY.

Explore the full profile